The Effects of Daily Anti-inflammatory Supplementation on Foundation Pain Index Scores in Chronic Opiate Patients
NCT05896878 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1
Last updated 2025-03-13
Summary
This is a research study to evaluate the effectiveness of daily supplementation with Root.Health, a plant-based dietary supplement, on reducing levels of 11 abnormal urine biomarkers associated with chronic pain. Biomarkers are molecules found in blood, tissues, or other body fluids (such as urine) that indicate normal or abnormal processes.
Conditions
- Pain, Chronic
- Opioid Dependence
- Opioid Use
- Inflammation Chronic
Interventions
- DIETARY_SUPPLEMENT
-
Root.Health Dietary Supplement
The Root.Health supplement is composed of six plant-based compounds with established roles in supporting innate physiological processes which are implicated in pain: tetrohydrocurcumin, ergothioneine, dihydroberberine, trans-resveratrol, ginger root extract, and methylcobalamin. Participants will take the provided supplement twice per day for the entire study duration in addition to pain management treatment protocols the participants currently follow.
Sponsors & Collaborators
-
Ethos Research & Development
collaborator INDUSTRY -
Hudson Medical
lead OTHER
Principal Investigators
-
Jonathann Kuo, MD · Medical Director, Hudson Medical
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-07-10
- Primary Completion
- 2024-08-10
- Completion
- 2024-09-10
Countries
- United States
Study Locations
More Related Trials
-
Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain
NCT01428583 ·Status: COMPLETED ·Phase: PHASE3
-
Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain
NCT00911287 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH)
NCT02192398 ·Status: TERMINATED ·Phase: NA
-
Herb-Opioid Interactions
NCT00027014 ·Status: COMPLETED ·Phase: PHASE4
-
Investigating Composite Biomarkers for Pain Catastrophizing
NCT04787198 ·Status: RECRUITING ·Phase: NA
-
Cannabidiol in Opioid Use Disorder and Chronic Pain
NCT04587791 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Study Evaluating MOA-728 Oral for the Treatment of OIBD in Subjects With Chronic Non-Malignant Pain
NCT00605644 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana
NCT00403117 ·Status: COMPLETED ·Phase: PHASE2
-
Determining the Clinical Relevance of the Interaction Between Enzalutamide and the Opioid Morphine and the DOAC Edoxaban
NCT05339672 ·Status: UNKNOWN
-
Enhancing Medication-based Analgesia in Humans- STUDY 2
NCT04036968 ·Status: COMPLETED ·Phase: PHASE2
-
Human Brain Adaptation to Chronic Pain and Its Effects on Opioid Use
NCT03248765 ·Status: TERMINATED
-
Using Technology to Track Pain and Pain-related Outcomes
NCT04267588 ·Status: RECRUITING
-
Attenuation of Pain in Men and Women
NCT01220414 ·Status: COMPLETED ·Phase: NA
-
Cessation of Long-term Opioid Therapy in Chronic Pain Patients
NCT02132221 ·Status: TERMINATED ·Phase: NA
-
Investigation of the Pharmacokinetic Profile of CBD
NCT05269706 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Characteristics of Chronic Pain in Patients With Addiction
NCT05976178 ·Status: COMPLETED
-
A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic Osteoarthritis (OA) Pain
NCT00631319 ·Status: COMPLETED ·Phase: PHASE3
-
To Assess the Rate and Extent of Absorption of Hydrocodone From 20 mg Hydrocodone Bitartrate Extended-Release Capsules
NCT02117141 ·Status: COMPLETED ·Phase: PHASE1
-
Dosing Intervals of Opioid Medication for Chronic Pain
NCT04132011 ·Status: WITHDRAWN ·Phase: PHASE4
-
Acute Pain Management in Patients on Opioid Replacement Therapy
NCT03933865 ·Status: TERMINATED ·Phase: PHASE1
-
Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance
NCT01681264 ·Status: TERMINATED ·Phase: PHASE4
-
Effects of Food on Oxycodone Pharmacokinetics in Healthy Volunteers
NCT02117583 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A
NCT05049733 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Interactions of Cannabidiol (CBD) With Morphine
NCT05143424 ·Status: RECRUITING ·Phase: PHASE1
-
A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Non-fasting Conditions
NCT00864357 ·Status: COMPLETED ·Phase: PHASE1